<a href="https://www.fiercebiotech.com/medtech/cequr-nabs-100m-series-e-boost-commercial-operations-its-insulin-delivery-patch" hreflang="en">CeQur nabs $100M series E to fuel insulin patch commercialization</a>
CeQur has secured $100 million in a Series E funding round to enhance the commercialization of its insulin delivery patch, CeQur Simplicity, which recently received FDA clearances allowing for extended use and dosing options. The funding will support growth initiatives and expand the company's sales team to reach more healthcare providers.
CeQur's recent $100 million Series E funding round, aimed at accelerating the commercialization of its FDA-cleared insulin delivery patch, signals a strong growth opportunity in the medtech space for innovative diabetes management solutions. As a professional tracking healthtech and medtech, this development highlights a significant investment signal, indicating potential market expansion and increased adoption of digital health devices that enhance patient convenience and adherence.